Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 111Neoplasms 22Neoplasm Metastasis 17Brain Neoplasms 15Breast Neoplasms, Male 13Head and Neck Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Stomach Neoplasms 5Glioblastoma 5Colorectal Neoplasms 5Prostatic Neoplasms 4Ovarian Neoplasms 4Inflammatory Breast Neoplasms 4Carcinoma, Ovarian Epithelial 4Salivary Gland Neoplasms 3Lung Neoplasms 3Gliosarcoma 3Glioma 3Ependymoma 3Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 2Solid Tumors 2Recurrence 2Osteitis Deformans 2Oligodendroglioma 2Neuroma, Acoustic 2Neurofibromatosis 2 2Gallbladder Neoplasms 2Esophageal Neoplasms 2

Interventions

Sunitinib 3Thymectomy 2Taxes 2Prednisone 2Pemetrexed 2Paclitaxel 2Octreotide 2Imatinib Mesylate 2Erlotinib Hydrochloride 2Cisplatin 2Carboplatin 2vorolanib 1regorafenib 1pembrolizumab 1olaparib 1lenvatinib 1entinostat 1bosutinib 1belinostat 1atezolizumab 1anetumab ravtansine 1amrubicin 1Ramucirumab 1Radiotherapy 1Radiosurgery 1Radiofrequency Ablation 1Psychiatric Rehabilitation 1Prednisolone 1Patient Comfort 1Palliative Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Thymoma × Lapatinib × Clear all
NCT01306045 2024-10-01

Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
647 enrolled 17 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Thymoma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡